glp-1 and ghrelin Figure 2 from Ghrelin, CCK, GLP-1, PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB Hormonal changes and diagram of

Recent Developments In March 2025, Novo Nordisk signed a deal worth up to $2 billion for the rights to UBT251, a new obesity and diabetes drug developed by United BioTechnology

Selected Publications Jiang J, Hu Z, Lyons KM, "Design and Analysis of CCN Gene Activity Using CCN Knockout Mice Containing LacZ Reporters", In: Methods Mol

Szarka A, Tomasskovics B, Banhegyi G (2012) The ascorbate-glutathione-alpha-tocopherol triad in abiotic stress response

11 BrouwerB

When semaglutide and lifestyle interventions were discontinued on the individuals from the STEP 1 trial, they regained the majority of their weight lost

Baric I, Zschocke J, Christensen E, Duran M, Goodman SI, Leonard JV, Muller E, Morton DH, Superti-Furga A, Hoffmann GF: Diagnosis and management of glutaric aciduria type I